Nova Scotia Health Partners with Medable


Medable has announced that its DCT platform was selected by the Nova Scotia Health Innovation Hub to increase the accessibility of oncology care for remote patients in rural Nova Scotia, with the long-term aim to improve patient access and trial diversity across Canada.

Read more about the new partnership here.

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.